Published in Metabolism on March 01, 1969
The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man. J Clin Invest (1971) 0.97
Studies on the relationship between plasma free fatty acids and growth hormone secretion in man. J Clin Invest (1972) 0.91
Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes (1970) 3.12
Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest (1975) 2.04
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab (1991) 1.96
Adrenergic receptor control mechanism for growth hormone secretion. J Clin Invest (1968) 1.60
Down regulation of insulin receptors in primary cultures of adult rat hepatocytes in monolayer. Endocrinology (1978) 1.27
Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions. Diabetes (1974) 1.23
Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. J Clin Invest (1995) 1.16
Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab (1989) 1.16
Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab (1988) 1.14
Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. J Clin Invest (1979) 1.11
Stimulatory effect of exogenous catecholamines on plasma HGH concentrations in presence of beta adrenergic blockade. Metabolism (1970) 1.10
Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans. Putative signaling mechanism linking peripheral and hepatic events. Diabetes (1989) 1.09
Insulin-secreting bronchial carcinoid tumor with widespread metastases. Am J Med (1968) 1.08
In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. Am J Physiol (1991) 1.07
Perifusion of pancreas fragments. A system for the study of dynamic aspects of insulin secretion. Diabetes (1974) 1.00
Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast. J Clin Endocrinol Metab (1992) 0.97
Central nervous system insulin receptors in normal and diabetic rats. Endocrinology (1979) 0.96
Portal vein insulin concentrations in diabetic subjects. Diabetes (1971) 0.95
Effect of lithium on pancreatic islet insulin release. Endocrinology (1978) 0.93
Effect of lipids on growth hormone secretion in humans. J Clin Invest (1971) 0.92
Effect of lipid and ketone infusions on insulin-induced growth hormone elevations in rhesus monkeys. Endocrinology (1969) 0.91
The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab (1987) 0.91
Hyperinsulinism in endotoxin shock dogs. Metabolism (1976) 0.90
Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis? FASEB J (1992) 0.89
An effect of hyposmolarity on insulin release in vitro. Am J Physiol (1975) 0.89
Evidence for dual control mechanism regulating hepatic glucose output in nondiabetic men. Diabetes (1991) 0.88
Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms. J Clin Endocrinol Metab (1989) 0.87
Galactorrhea-amenorrhea syndrome: follow-up of forty-five patients after pituitary tumor removal. Ann Intern Med (1981) 0.86
Metabolism and actions of dehydroepiandrosterone in humans. J Steroid Biochem Mol Biol (1991) 0.85
Failure of a midnocturnal insulin infusion to suppress the increased insulin need for breakfast in insulin-dependent diabetic patients. Diabetes (1984) 0.84
Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women. Am J Obstet Gynecol (1990) 0.84
The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome. Am J Obstet Gynecol (1989) 0.84
Pump-induced insulin aggregation. A problem with the Biostator. Diabetes (1985) 0.84
Insulin inhibits adrenal 17,20-lyase activity in man. J Clin Endocrinol Metab (1992) 0.83
Lack of effect of dehydroepiandrosterone in obese men. Int J Obes (1990) 0.83
Effect of streptozotocin on qualitative aspects of plasma insulin in a patient with a malignant islet cell tumor. J Clin Endocrinol Metab (1970) 0.83
Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM. Diabetes (1994) 0.82
Hypoglycemia during pregnancy following pancreatoduodenectomy. Metabolism (1971) 0.81
The surface structure of isolated pancreatic islet cells. Cell Tissue Res (1975) 0.81
Skeletal muscle lipids and glycogen mask substrate competition (Randle cycle). Metabolism (1993) 0.80
Effect of lipids on glucagon secretion in man. Metabolism (1975) 0.80
Effect of dietary composition on insulin receptors in normal subjects. Am J Clin Nutr (1979) 0.80
Effects of extreme hyperinsulinaemia on serum levels of trace metals, trace metal binding proteins, and electrolytes in normal females. Acta Endocrinol (Copenh) (1987) 0.80
Changes in phosphatidylcholine fatty acid composition are associated with altered skeletal muscle insulin responsiveness in normal man. Metabolism (2000) 0.79
Accelerated decline in hepatic glucose production during fasting in normal women compared with men. Metabolism (1989) 0.79
Absorption characteristic of breakfast determines insulin sensitivity and carbohydrate tolerance for lunch. Diabetes Care (1989) 0.79
Role of ERCP in asymptomatic orthotopic liver transplant patients with abnormal liver enzymes. Am J Gastroenterol (2000) 0.79
Skeletal muscle phosphatidylcholine fatty acids and insulin sensitivity in normal humans. Am J Physiol (1998) 0.79
Effect of down-regulation of insulin receptors on receptor-antibody binding. Endocrinology (1981) 0.78
Endoscopic removal of a "floating" biliary Gianturco Z stent five years after placement for a benign anastomotic stricture in a liver transplant patient. Gastrointest Endosc (1997) 0.78
Downregulation of insulin receptors in obese man. Diabetes (1979) 0.78
Mechanisms of action of diazoxide. J Lab Clin Med (1967) 0.78
Adrenergic control mechanism for vasopressin-induced plasma growth hormone response. Metabolism (1968) 0.78
Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome. J Clin Endocrinol Metab (1980) 0.78
Insulin secretion in hypothermic dogs. Am J Physiol (1967) 0.78
Relation of serum molindone levels to serum prolactin levels and antipsychotic response. J Clin Psychiatry (1989) 0.77
The neuroendocrine and behavioral response to dextroamphetamine in normal individuals. Biol Psychiatry (1984) 0.77
Diabetes and hypoglycemia due to insulin antibodies. Am J Med (1978) 0.77
Radioimmunoassay of the A-chain of insulin. Diabetes (1967) 0.77
Prolonged insulin resistance following insulin-induced hypoglycaemia. Diabetologia (1987) 0.77
Influence of nucleotide derivatives on lipolysis and lipid peroxide formation in vitro. Metabolism (1967) 0.77
The treatment of acromegaly by transsphenoidal surgery. Arch Intern Med (1980) 0.77
Impaired modulation of hepatic glucose output overnight after a 72-h fast in normal man. J Clin Endocrinol Metab (1990) 0.77
Role of insulin receptors in obesity-related diabetes. Horm Metab Res (1982) 0.76
Reduced insulin clearance in normal subjects due to extreme hyperinsulinemia. Am J Med Sci (1988) 0.76
Amphetamine response in borderline patients. Psychiatry Res (1985) 0.76
Role of hepatocyte plasma membrane in insulin degradation. Am J Physiol (1985) 0.76
Increased transcapillary escape rate of albumin in nondiabetic men in response to hyperinsulinemia. Diabetes (1990) 0.76
Evidence for dissociation of gluconeogenesis stimulated by non-esterified fatty acids and changes in fructose 2,6-bisphosphate in cultured rat hepatocytes. Biochem J (1992) 0.75
Down regulation of insulin receptors. Trans Am Clin Climatol Assoc (1979) 0.75
Diarrhea of endocrine origin. J La State Med Soc (1966) 0.75
Sleep apnea in active acromegaly. Arch Intern Med (1985) 0.75
Effect of Anti-Insulin Receptor Antibody on Insulin Dissociation from IM-9 lymphocytes. Horm Metab Res (1981) 0.75
Medical conditions that affect the breast and lactation. Clin Obstet Gynecol (1975) 0.75
Effect of ketones on plasma growth hormone concentrations. J Endocrinol (1969) 0.75
Effect of L-tryptophan on growth hormone and prolactin release in normal volunteers and patients with secretory pituitary tumors. Horm Metab Res (1979) 0.75
Pachydermoperiostosis: a review and presentation of a case with associated Graves' disease. South Med J (1971) 0.75
Submaxillary gland removal. Effects on glucose and insulin homeostasis. Arch Otolaryngol (1971) 0.75
Effect of chlorophenoxyisobutyric acid (CPIB) on adrenaline-induced lipolysis in vitro. J Atheroscler Res (1968) 0.75
Hyperresponsiveness to tolbutamide of dogs pretreated with diazoxide. Metabolism (1971) 0.75
A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease. N Engl J Med (1981) 0.75
Cholinergic blockade and growth hormone responsiveness to insulin hypoglycemia. Proc Soc Exp Biol Med (1969) 0.75
Portal and peripheral vein immunoreactive insulin concentrations following tolbutamide administration. Diabetes (1971) 0.75
Inhibition of insulin binding by concanavalin-A. Metabolism (1980) 0.75
The effect of hyperosmolarity on muscle glycogen accumulation. Horm Metab Res (1992) 0.75
Effects of thyrotropin-releasing hormone and metoclopramide in patients with phenothiazine-induced hyperprolactinemia. J Clin Endocrinol Metab (1981) 0.75
Effect of clofibrate and high fat diets on adrenaline-induced lipolysis in isolated rat adipose tissue. J Atheroscler Res (1970) 0.75
Control of growth hormone secretion in man. Postgrad Med J (1973) 0.75
Insulin processing by cultured hepatocytes. Am J Physiol (1986) 0.75
Effect of growth hormone deficiency on glucagon secretion. Proc Soc Exp Biol Med (1973) 0.75
[Insulin secretion, measured by intraportal and peripheral insulin determinations, in normal and diabetic subjects]. Journ Annu Diabetol Hotel Dieu (1972) 0.75
Transsphenoidal removal of pituitary tumors: experience with 167 patients. Va Med (1982) 0.75
The effect of lipids on prolactin and growth hormone secretion. Horm Metab Res (1977) 0.75
Effect of lipids on growth hormone synthesis by isolated pituitaries. Proc Soc Exp Biol Med (1971) 0.75
Anti-insulin receptor antibodies and diabetes. Ann Intern Med (1977) 0.75
Integration of the secretory control mechanisms for insulin, glucagon, and growth hormone. Curr Top Exp Endocrinol (1974) 0.75